Compounds > sulfinpyrazone
Page last updated: 2024-11-04

sulfinpyrazone and Carbohydrate Inducible Hyperlipemia

sulfinpyrazone has been researched along with Carbohydrate Inducible Hyperlipemia in 1 studies

Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sommariva, D1
Scotti, L1
Baroni, L1
Beggi, P1
Fasoli, A1

Other Studies

1 other study available for sulfinpyrazone and Carbohydrate Inducible Hyperlipemia

ArticleYear
[Sulfinpyrazone and lipoproteins: absence of effects on serum lipids in hyperlipoproteinemias of types II and IV].
    La Clinica terapeutica, 1980, Mar-31, Volume: 92, Issue:6

    Topics: Adult; Cholesterol; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Lipi

1980